Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects. Epitope spreading versus clonal persistence

Brain

Volumn 123, Issue 3, 2000, Pages 508-518

  Goebels, Norbert ^a,b   Hofstetter, Harald ^a   Schmidt, Stephan ^a   Brunner, Christoph ^a   Wekerle, Hartmut ^a   Hohlfeld, Reinhard ^a,b,c  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Autoimmunity; Immunotherapy; Multiple sclerosis; Repertoire; T lymphocytes

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033976207     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.3.508     Document Type: Article

References (41)

1. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. [Review]. Science 1996; 272: 54-60.
2. Besser M, Wank R. Clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 1999; 162: 6303-6.
3. Cochet M, Pannetier C, Regnault A, Darche S, Leclerc C, Kourilsky P. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol 1992; 22: 2639-47.
4. Cohen IR. The cognitive paradigm and the immunological homunculus. [Review]. Immunol Today 1992; 13: 490-4.
5. Dutton RW, Bradley LM, Swain SL. T cell memory. [Review]. Annu Rev Immunol 1998; 16: 201-23.
6. Eylar EH, Kniskern PJ, Jackson JJ. Myelin basic proteins. Methods Enzymol 1979; 32B: 323-41.
7. Gran B, Hemmer B, Vergelli M, McFarland HF, Martin R. Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann Neurol 1999; 45: 559-67.
8. Hafler DA, Saadeh MG, Kuchroo VK, Milford E, Steinman L. TCR usage in human and experimental demyelinating disease. [Review]. Immunol Today 1996; 17: 152-9.
9. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, et al. Identification of high potency microbial and self ligands for a human autoreactive class H-restricted T cell clone. J Exp Med 1997; 185: 1651-9.
10. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. [Review]. Brain 1997; 120: 865-916.
11. Hohlfeld R, Meinl E, Weber F, Zipp F, Schmidt S, Sotgiu S, et al. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. [Review]. Neurology 1995; 45 (6 Suppl 6): S33-8.
12. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WEF, et al. Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999; 189: 865-70.
13. Lassmann H, Wekerle H. Experimental models of multiple sclerosis. In: Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H, editors. McAlpine's multiple sclerosis. London: Churchill Livingston; 1998. p. 409-33.
14. Liu D, Callahan JP, Dau PC. Intrafamily fragment analysis of the T cell receptor beta chain CDR3 region. J Immunol Methods 1995; 187: 139-50.
15. Lovett-Racke AE, Martin R, McFarland HF, Racke MK, Utz U. Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis. J Neuroimmunol 1997; 78: 162-71.
16. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. [Review]. Annu Rev Immunol 1992; 10: 153-87.
17. Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis: complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 1993; 92: 2633-43.
18. Meinl E, Hoch RM, Dornmair K, de Waal Malefyt R, Bontrop RE, Jonker M, et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am J Pathol 1997; 150: 445-53.
19. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999; 5: 49-55.
20. + T cells in multiple sclerosis. Autoimmunity 1996; 23: 127-38.
21. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. [Review]. Immunol Today 1995; 16: 176-81.
22. Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 1990a; 40: 1770-6.
23. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, et al. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 1990b; 87: 7968-72.
24. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994; 153: 2807-18.
25. Salvetti M, Ristori G, D'Amato M, Buttinelli C, Falcone M, Fieschi C, et al. Predominant and stable T-cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 1993; 23: 1232-9.
26. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. [Review]. Annu Rev Immunol 1993; 11: 729-66.
27. Sprent J. T and B memory cells. [Review]. Cell 1994; 76: 315-22.
28. Steinman L. Absence of 'original antigenic sin' in autoimmunity provides an unforeseen platform for immune therapy. J Exp Med 1999; 189: 1021-4.
29. Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. [Review]. Crit Rev Immunol 1997; 17: 33-75.
30. Tuohy VK, Yu M, Weinstock-Guttman B, Kinkel RP. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 1997; 99: 1682-90.
31. Tuohy VK, Yu M, Yin L, Kawczak JA, Johnson JA, Mathisen PM, et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. [Review]. Immunol Rev 1998; 164: 93-100.
32. Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 1999; 189: 1033-42.
33. Uccelli A, Giunti D, Salvetti M, Ristori G, Fenoglio D, Abbruzzese M, et al. A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. Clin Exp Immunol 1998; 111: 186-92.
34. Ufret-Vincenty RL, Quigley L, Tresser N, Pak S-H, Gado A, Hausmann S, et al. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J Exp Med 1998; 188: 1725-38.
35. Vandevyver C, Mertens N, van den Elsen P, Medaer R, Raus J, Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995; 25: 958-68.
36. Vincent A, Willcox N, Hill M, Curnow J, MacLennan C, Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. [Review]. Immunol Rev 1998; 164: 157-68.
37. Viret C, Wong FS, Janeway CA. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide: self-MHC complex recognition. Immunity 1999; 10: 559-68.
38. Voskuhl RR. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance. Immunol Rev 1998; 164: 81-92.
39. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
40. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152: 5581-92.
41. Zinkernagel RM, Bachmann MF, Kündig TM, Gehen S, Pirchet H, Hengartner H. On immunological memory. [Review]. Annu Rev Immunol 1996; 14: 333-67.